Determinants of Aorta Heterogeneity
主动脉异质性的决定因素
基本信息
- 批准号:10618144
- 负责人:
- 金额:$ 83.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAneurysmAortaAortic DiseasesAtherosclerosisBasic ScienceBiologicalBiologyBrainCell physiologyCellsCharacteristicsClinicalDataDiseaseDissectionEmbryoExtracellular MatrixFundingHeterogeneityInflammationKidneyLengthLifeLipoproteinsLungMagnetic Resonance ImagingMedicalMetabolismMolecularOperative Surgical ProceduresOrganPathogenesisPatient observationPharmaceutical PreparationsProteomicsReagentResearchRuptureScientistSignal PathwaySkinSpecificitySyndromeTechniquesTherapeuticTissuesTrainingTranslational ResearchUltrasonographyboneextracellularflexibilityinsightintravital microscopymouse modelnext generationnovelprogramssingle-cell RNA sequencingtooltranscriptomics
项目摘要
Abstract
Aortopathies, including aneurysms, dissection, and rupture, represent a key challenge in HLBS
research. In the past twenty years of our continuously funded research on aortopathies, we
have contributed to many mechanistic insights into the aortopathy research including a new
concept: There are regional characteristics of the aorta in regard to diverse embryonic origins
and functions of cells. The overall hypothesis of this R35 program is that heterogeneity of
cellular origins imparts functional variances along the length of the aorta, including diversity of
extracellular matrix stability, which in turn contributes to regional specificity of aortopathies.
Regional specificity of aortopathies is present in many mouse models that we have validated
and characterized. Our initial single cell transcriptomic and proteomic data have also implicated
new potential contributors to heterogeneity of the normal aortic biology and aortopathies. Three
major themes are proposed in this program: (1) What are the structural and molecular
mechanisms that contribute to biological and pathophysiological heterogeneity along the length
of the aorta? (2) Are cellular and extracellular heterogeneity a basis for regional specificity of
aortopathies? (3) How do signaling pathways, extracellular matrix, and crosstalk between
resident aortic cells coordinate to promote the heterogeneity of aortopathies? We have robust
tools including a spectrum of reagents, multiple classic and new mouse models,
ultrasonography, MRI, intravital microscopy, proteomics, and single cell RNA sequencing
techniques. In addition to aortopathy research, the PI has more than 30-year expertise in the
fields of lipoprotein metabolism, inflammation, and atherosclerosis research. Aortopathies are
not a sole aortic disease, but is associated with a wide range of diseases or syndromes that
may affect skin, lung, kidney, brain, bone, and other organs. The proposed research program
will benefit from the flexibility to pursue potential contributions of other tissues and organs to
aortopathies, and vice versa the influences of aortopathies on other tissues and organs. This
R35 mechanism will also benefit the PI’s strength in basic research, enhance his interaction with
the translational research in the clinical arena, and train the next generation of scientists.
摘要
动脉病变,包括动脉瘤、夹层和破裂,是HLBS的一个关键挑战。
研究。在过去的二十年里,我们不断地资助关于大动脉疾病的研究,我们
为大动脉病变的研究提供了许多机械论的见解,包括一项新的
概念:不同胚胎起源的大动脉具有区域性特征。
和细胞的功能。该R35计划的总体假设是
细胞起源赋予了沿主动脉长度的功能差异,包括
细胞外基质的稳定性,这反过来又有助于动脉病变的区域特异性。
在我们已经证实的许多小鼠模型中存在动脉病变的区域特异性
并以此为特征。我们最初的单细胞转录组和蛋白质组学数据也表明
导致正常主动脉生物学和主动脉病变异质性的新的潜在因素。三
本计划提出的主要主题是:(1)什么是结构和分子
导致生物和病理生理沿长度方向异质性的机制
(2)细胞和细胞外的异质性是动脉局部特异性的基础吗?
主动脉病变?(3)信号通路、细胞外基质和相互间的串扰是如何
驻留的主动脉细胞协调以促进主动脉病变的异质性?我们有健壮的
工具包括一系列试剂,多种经典和新的鼠标模型,
超声、核磁共振、活体显微镜、蛋白质组学和单细胞RNA测序
技巧。除了大动脉疾病的研究外,PI还拥有30多年的
脂蛋白代谢、炎症和动脉粥样硬化研究领域。主动脉病变是
不是唯一的主动脉疾病,但与一系列疾病或综合征有关,
可影响皮肤、肺、肾、脑、骨等器官。建议的研究计划
将受益于寻求其他组织和器官的潜在贡献的灵活性
主动脉病变对其他组织和器官的影响,反之亦然。这
R35机制也将有利于PI在基础研究方面的实力,加强他与
在临床领域进行转化性研究,培养下一代科学家。
项目成果
期刊论文数量(25)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Embryonic Heterogeneity of Smooth Muscle Cells in the Complex Mechanisms of Thoracic Aortic Aneurysms.
- DOI:10.3390/genes13091618
- 发表时间:2022-09-09
- 期刊:
- 影响因子:3.5
- 作者:Ito, Sohei;Lu, Hong S.;Daugherty, Alan;Sawada, Hisashi
- 通讯作者:Sawada, Hisashi
Forty-Year Anniversary of Arteriosclerosis, Thrombosis, and Vascular Biology.
动脉硬化,血栓形成和血管生物学40周年。
- DOI:10.1161/atvbaha.121.316755
- 发表时间:2021-09
- 期刊:
- 影响因子:0
- 作者:Daugherty A;Fisher EA;Taubman MB;Heistad DD;Fogelman AM
- 通讯作者:Fogelman AM
Key Factors for Improving Rigor and Reproducibility: Guidelines, Peer Reviews, and Journal Technical Reviews.
- DOI:10.3389/fcvm.2022.856102
- 发表时间:2022
- 期刊:
- 影响因子:3.6
- 作者:Lu HS;Daugherty A
- 通讯作者:Daugherty A
Molecular Regulation of Heme Oxygenase-1 Expression by E2F Transcription Factor 2 in Lung Fibroblast Cells: Relevance to Idiopathic Pulmonary Fibrosis.
- DOI:10.3390/biom12101531
- 发表时间:2022-10-21
- 期刊:
- 影响因子:5.5
- 作者:
- 通讯作者:
Expression of a PCSK9 Gain-of-Function Mutation in C57BL/6J Mice to Facilitate Angiotensin II-Induced AAAs.
- DOI:10.3390/biom12070915
- 发表时间:2022-06-29
- 期刊:
- 影响因子:5.5
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alan Daugherty其他文献
Alan Daugherty的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alan Daugherty', 18)}}的其他基金
Acquisition of Shared Thermoneutral Rodent Housing Resources
获取共享的热中性啮齿动物住房资源
- 批准号:
10734172 - 财政年份:2023
- 资助金额:
$ 83.96万 - 项目类别:
Atherosclerosis Mechanisms: Angiotensin II production and action
动脉粥样硬化机制:血管紧张素 II 的产生和作用
- 批准号:
9903447 - 财政年份:2018
- 资助金额:
$ 83.96万 - 项目类别:
Atherosclerosis Mechanisms: Angiotensin II production and action
动脉粥样硬化机制:血管紧张素 II 的产生和作用
- 批准号:
10132375 - 财政年份:2018
- 资助金额:
$ 83.96万 - 项目类别:
Adventitial-medial interactions in thoracic aortic diseases
胸主动脉疾病中外膜-内侧相互作用
- 批准号:
9160051 - 财政年份:2016
- 资助金额:
$ 83.96万 - 项目类别:
相似海外基金
Dissecting the role of hemodynamics in ascending aorta aneurysm development in bicuspid aortic valve disease
剖析血流动力学在二叶式主动脉瓣疾病升主动脉瘤发展中的作用
- 批准号:
500274 - 财政年份:2022
- 资助金额:
$ 83.96万 - 项目类别:
Studentship Programs
Transgenic fluorescent zebrafish as tools to characterize prostaglandin EP4 receptor gene expression and to discover drug candidates for abdominal aorta aneurysm
转基因荧光斑马鱼作为表征前列腺素 EP4 受体基因表达和发现腹主动脉瘤候选药物的工具
- 批准号:
20K17730 - 财政年份:2020
- 资助金额:
$ 83.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and Dissection
胸主动脉瘤和夹层中的平滑肌细胞增殖和降解表型
- 批准号:
10184861 - 财政年份:2020
- 资助金额:
$ 83.96万 - 项目类别:
Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and Dissection
胸主动脉瘤和夹层中的平滑肌细胞增殖和降解表型
- 批准号:
10376852 - 财政年份:2019
- 资助金额:
$ 83.96万 - 项目类别:
Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and Dissection
胸主动脉瘤和夹层中的平滑肌细胞增殖和降解表型
- 批准号:
10132382 - 财政年份:2019
- 资助金额:
$ 83.96万 - 项目类别:
Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and Dissection
胸主动脉瘤和夹层中的平滑肌细胞增殖和降解表型
- 批准号:
10573756 - 财政年份:2019
- 资助金额:
$ 83.96万 - 项目类别:
Smooth Muscle Cell Proliferation and Degradative Phenotype in Thoracic Aorta Aneurysm and Dissection
胸主动脉瘤和夹层中的平滑肌细胞增殖和降解表型
- 批准号:
9904189 - 财政年份:2019
- 资助金额:
$ 83.96万 - 项目类别:
Dissecting the role of hemodynamics in ascending aorta aneurysm development
剖析血流动力学在升主动脉瘤发展中的作用
- 批准号:
403550 - 财政年份:2019
- 资助金额:
$ 83.96万 - 项目类别:
Operating Grants
The elucidation of a molecular mechanism of N-type calcium channel on pathogenesis and development of abdominal aorta aneurysm
N型钙通道在腹主动脉瘤发生发展中的分子机制的阐明
- 批准号:
17K16592 - 财政年份:2017
- 资助金额:
$ 83.96万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of a Biological Stent Graft for Aorta Aneurysm Repair
用于主动脉瘤修复的生物覆膜支架的开发
- 批准号:
7804697 - 财政年份:2010
- 资助金额:
$ 83.96万 - 项目类别: